[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-100522025--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-100522025","PRESSRELEASE"," Baebies Partners with Medical Horizons to Bring SEEKER Newborn Screening Platform to Italy","2022-05-10T07:24:20.000+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> FLORENCE, Italy, May 10, 2022 \u002FPRNewswire\u002F -- Baebies(®), a growth-stage medical device company developing innovative products to enable early disease detection and multifunctional diagnostic testing for children and adults., in partnership with medical device supplier Medical Horizons, today announced newborns in Italy are being screened with the Baebies \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fc212.net\u002Fc\u002Flink\u002F?t=0&l=en&o=3528082-1&h=3179285251&u=https%3A%2F%2Fbaebies.com%2Fproducts%2Fseeker%2F&a=SEEKER%C2%AE\">SEEKER(®)\u003C\u002Fa> platform.\u003C\u002Fp>\u003Cp> \u003Cimg border=\"0\" src=\"https:\u002F\u002Fmma.prnewswire.com\u002Fmedia\u002F465102\u002FBaebies_Inc_Logo.jpg\"\u002F>\u003C\u002Fp>\u003Cp> The Newborn Screening, Clinical Chemistry, and Pharmacology Lab at Meyer Children's Hospital in Florence becomes the first lab in Italy to screen newborns for lysosomal storage disorders (LSDs) including Pompe disease, Mucopolysaccharidosis type I, Fabry, and Gaucher on the SEEKER platform.\u003C\u002Fp>\u003Cp> Powered by digital \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fc212.net\u002Fc\u002Flink\u002F?t=0&l=en&o=3528082-1&h=2783286643&u=https%3A%2F%2Fbaebies.com%2Fresources%2Ftechnology%2F&a=digital+microfluidics\">microfluidics\u003C\u002Fa> technology, SEEKER is an FDA-cleared and CE-marked newborn screening platform for LSDs. It's flexible, high throughput laboratory solution provides newborn screening results in under 3 hours for multiple LSDs from a single dried blood spot specimen.\u003C\u002Fp>\u003Cp> \"Our continued expansion of digital microfluidics technology into new global markets represents exciting opportunities to screen more babies and save more lives,\" said Vamsee Pamula, Co-Founder and President of Baebies. \"We look forward to many more opportunities with Medical Horizons.\"\u003C\u002Fp>\u003Cp> The technology selection process at Meyer Children's Hospital was led by Dr. Giancarlo la Marca, deputy department head of the Newborn Screening, Clinical Chemistry, and Pharmacology Lab. Dr. la Marca is a recognized global authority in newborn screening, who works closely with the International Society for Neonatal Screening to advance research and adoption of newborn screening around the world.\u003C\u002Fp>\u003Cp> \"There is not one perfect solution for all newborn screening. It is important to use the best tool for each condition,\" said Dr. la Marca. \"Using digital microfluidics technology to screen for lysosomal storage disorders frees up our mass spectrometer for other testing and research.\"\u003C\u002Fp>\u003Cp> Other key criteria contributing to selection of the SEEKER platform were its compact size and ease of use.\u003C\u002Fp>\u003Cp> Currently, newborn screening for LSDs is not mandatory in Italy. However, an amendment to current newborn screening legislation could expedite inclusion of new conditions like LSDs in screening panels around the country.\u003C\u002Fp>\u003Cp> \"Our goal is to ensure that the labs we serve are prepared when screening becomes mandatory,\" said Guido Osti, CEO of Medical \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fc212.net\u002Fc\u002Flink\u002F?t=0&l=en&o=3528082-1&h=2039569074&u=https%3A%2F%2Fwww.medicalhorizons.it%2F&a=Medical+Horizons\">Horizons.\u003C\u002Fa> \"The launch of SEEKER in this first location in Florence is an important step forward.\"\u003C\u002Fp>\u003Cp> About Baebies Guided by the vision that \"everyone deserves a healthy start,\" \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fc212.net\u002Fc\u002Flink\u002F?t=0&l=en&o=3528082-1&h=669952758&u=https%3A%2F%2Fbaebies.com%2F&a=Baebies\">Baebies\u003C\u002Fa> delivers millions of tests globally every year to save lives and make lives better. Baebies is a pioneer in digital microfluidics, which maximizes diagnostic yield from low-volume samples. Headquartered in Durham, North Carolina, their products are used in central laboratories and point-of-care settings worldwide.\u003C\u002Fp>\u003Cp> About Medical Horizons Medical Horizons was created to identify medical innovation worldwide, that had the potential to become innovative new products and then develop their commercialization with the most selected Italian sales network. Medical Horizons' expertise includes understanding the commercial interest that innovative device will have for the Italian Market so to ensure that these products will meet the perceived need of prospective acquirers.\u003C\u002Fp>\u003Cp> Logo - \u003Cimg border=\"0\" src=\"https:\u002F\u002Fc212.net\u002Fc\u002Flink\u002F?t=0&l=en&o=3528082-1&h=1953707570&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F465102%2FBaebies_Inc_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F465102%2FBaebies_Inc_Logo.jpg\"\u002F>\u003C\u002Fp>\u003Cp> CONTACT:  Meghan Kofod, (919) 605 - 5449, mkofod@baebies.com\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","FLORENCE, Italy, May 10, 2022 \u002FPRNewswire\u002F -- Baebies(®), a growth-stage medical device company developing innovative products to enable early disease detection",[16,21,26,31,36,41,46,51,56,60],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-241026062"," team.blue verlengt een tranche van 1,1 miljard euro uit zijn termijnlening B tot 2032, bij de grootste uitgifte van een termijnlening in euro in ","2026-10-24T18:32:25.000+02:00","GENT, België, 24 oktober 2026 \u002FPRNewswire\u002F -- team.blue, een toonaangevende pan-Europese aanbieder van digitale oplossingen voor mkb's (kmo's), gesteund door Hg",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-231026126"," Qatar's Years of Culture Initiative Announces Partner Countries Through 2030","2026-10-23T18:52:24.000+02:00","Italy, the Netherlands, Switzerland, Portugal and Spain named future Years of Culture partners DOHA, Qatar, Oct. 23, 2026 \u002FPRNewswire\u002F -- The Years of Culture i",{"id":27,"title":28,"pubDate":29,"logoUrl":8,"thirdParty":11,"orgId":13,"description":30},"CSN-231026122"," Sungrow Shares Perspectives on Europe's Energy Transition at BloombergNEF London Summit","2026-10-23T18:03:24.000+02:00","LONDON, Oct. 23, 2026 \u002FPRNewswire\u002F -- As Europe experiences growing energy transition demands with deeper electrification and smarter grid integration emerging ",{"id":32,"title":33,"pubDate":34,"logoUrl":8,"thirdParty":11,"orgId":13,"description":35},"CSN-231026109"," THE POWER OF WILL: A SERIES OF CONVERSATIONS ABOUT DETERMINATION AND INDIVIDUALITY","2026-10-23T16:38:25.000+02:00","MIAMI, Oct. 23, 2026 \u002FPRNewswire\u002F -- Armani beauty: The Power of WILL is a video interview series hosted by artist and digital storyteller Devon Rodriguez. Comb",{"id":37,"title":38,"pubDate":39,"logoUrl":8,"thirdParty":11,"orgId":13,"description":40},"CSN-231026103"," Lassa introduces new winter tyre Wintus 3 for light commercial vehicles","2026-10-23T16:22:25.000+02:00","Lassa, the international tyre brand of Brisa, Türkiye's tyre industry leader, has developed Wintus 3 as a dedicated winter tyre for light commercial vehicle use",{"id":42,"title":43,"pubDate":44,"logoUrl":8,"thirdParty":11,"orgId":13,"description":45},"CSN-231026101"," TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026","2026-10-23T16:03:24.000+02:00","GREATER NOIDA, India, Oct. 23, 2026 \u002FPRNewswire\u002F -- The Renewable Energy India Expo (REI) opened on October 22 at the India Expo Centre in Greater Noida. As one",{"id":47,"title":48,"pubDate":49,"logoUrl":8,"thirdParty":11,"orgId":13,"description":50},"CSN-231026095"," RINA: Paolo Moretti appointed Group Chief Executive Officer","2026-10-23T15:37:24.000+02:00","GENOA, Italy, Oct. 23, 2026 \u002FPRNewswire\u002F -- RINA S.p.A.'s new Board of Directors has appointed Paolo Moretti, currently General Manager, as Group Chief Executiv",{"id":52,"title":53,"pubDate":54,"logoUrl":8,"thirdParty":11,"orgId":13,"description":55},"CSN-231026084"," XbotGo Named World's No. 1 Consumer Team Sports AI Tracking Camera Brand","2026-10-23T15:01:26.000+02:00","XbotGo recognized as the market leader in consumer team sports AI tracking technology based on 2025 unit sales. MOUNTAIN VIEW, Calif., Oct. 23, 2026 \u002FPRNewswire",{"id":57,"title":58,"pubDate":54,"logoUrl":8,"thirdParty":11,"orgId":13,"description":59},"CSN-231026085"," Anycubic and Thingiverse Announce Exclusive Partnership to Expand Access to 3D Models","SHENZHEN, China, Oct. 23, 2026 \u002FPRNewswire\u002F -- Anycubic, a global brand in 3D printing, announced an exclusive partnership with Thingiverse, one of the largest ",{"id":61,"title":62,"pubDate":63,"logoUrl":8,"thirdParty":11,"orgId":13,"description":64},"CSN-231026082"," Infosys:Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues","2026-10-23T14:58:24.000+02:00","- Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth - FY 27 revenue guidance revised to 1%-2% and margin guidan"]